Remus Pharma IPO Details ( Remus Pharmaceuticals Limited IPO Review )
(17 May 2023 – 19 May 2023)
Remus Pharmaceuticals Limited, established in 2015, specializes in the marketing and distribution of completed pharmaceutical drug formulations.
The product offerings of the company can be classified into two major categories: pharmaceutical drugs and healthcare products.
- APIs are the essential constituents of drug products such as tablets, capsules, creams, and injectables, responsible for their desired medicinal effects.
- Finished pharmaceutical formulations refer to medicinal drugs that have undergone processing to be available in various dosage forms for therapeutic use.
As of January 31, 2023, Remus Pharmaceuticals Limited boasts a product portfolio comprising 429 diverse products. These products are marketed under various brand names worldwide. The company currently holds registrations for 295 of its products across 13 different countries. Additionally, as of January 31, 2023, Remus Pharmaceuticals Limited has 134 products in the registration process for approval in 16 countries.
As of January 31, 2023, Remus Pharmaceuticals had established business-to-business supply agreements with 58 domestic distributors and 139 international distributors. These agreements were in place for the purpose of distribution and/or contract manufacturing supply.
Remus Pharmaceuticals has built robust and reliable relationships with its customers, who are located across more than 20 countries. The company’s clientele encompasses a diverse range of entities, including generic distributors, regional distributors, multinational distributors, hospitals, and clinics.
Remus Pharmaceuticals Limited IPO Competitive Strength
- Experienced Promoters and Management Team
- Wide range of Products
- Strategic Location of Contract Manufacturing Facilities
- Diversified business operations and revenue base
- Scalable Business Model
Remus Pharmaceuticals IPO Financials Performance ( Results )
Remus Pharmaceuticals Limited Financial Information ( Restated )
All Amount in ₹ Lakhs
|Period Ended||Total Assets||Total Revenue||PAT||EPS|
Objective of IPO Issue
- To Meet Working Capital Requirements
- Funding investments for acquisitions and general corporate purposes
- To meet Public Issue Expenses
Remus Pharmaceuticals IPO Basic Details
|IPO Date||May 17, 2023 to May 19, 2023|
|Listing Date||Monday, May 29, 2023|
|Face Value||₹10 per share|
|Price||₹1150 to ₹1229 per share|
|Lot Size||100 Shares|
|Issue Size||388,000 shares|
(aggregating up to ₹47.69 Cr)
|Fresh Issue||388,000 shares|
(aggregating up to ₹47.69 Cr)
|Issue Type||Book Built Issue IPO|
|Listing At||NSE SME|
|QIB Shares Offered||50% of the Offer|
|NII (HNI) Shares Offered||15% of the Offer|
|Retail Shares Offered||35% of the Offer|
|Company Promoters||Mr. Arpit Deepakkumar Shah,|
Ms. Roma Vinodbhai Shah,
Mr. Swapnil Jatinbhai Shah And
Mrs. Anar Swapnil Shah
Remus Pharmaceuticals IPO Timetable
Remus Pharmaceuticals IPO will open on May 17, 2023 and close on May 19, 2023. You can join Remus Pharmaceuticals IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
|Opening Date||May 17, 2023|
|Closing Date||May 19, 2023|
|Basis of Allotment||May 24, 2023|
|Initiation of Refunds||May 25, 2023|
|Credit of Shares to Demat||May 26, 2023|
|Listing Date||May 29, 2023|
Remus Pharmaceuticals IPO Lot Size
For retail investors in Remus Pharmaceuticals IPO, 100 shares will come in 1 lot or the minimum investment will be ₹122,900. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹122,900.
Remus Pharmaceuticals IPO Promoter Holding
|Pre Issue Share Holding||92.82%|
|Post Issue Share Holding||–|
Remus Pharmaceuticals IPO Valuation – FY2022
|Earning Per Share (EPS)||₹33.86 per Equity Share|
|Price/Earning P/E Ratio||Coming Soon|
|Return on Net Worth (RoNW)||52.64%|
|Net Asset Value (NAV)||₹64.3 per Equity Share|
|Upper Price/Book Value (Price/BV) Ratio||Coming Soon|
Remus Pharmaceuticals Ltd Key Performance Indicator
|Market Cap (₹ Cr.)||133.35|
|P/E (x)||Coming Soon|
Remus Pharmaceuticals Ltd Peer Comparison
|Trident Lifeline Limited||Standalone||148.50||10||6.92||21.46||82.66||5.97||3.41|
|Chandra Bhagat Pharma|
Remus Pharmaceuticals IPO GMP Live Update, Kostak Rate day by day
|26 May 2023||₹550||–||–|
|25 May 2023||₹500||–||–|
|24 May 2023||₹450||–||–|
|23 May 2023||₹430||–||–|
|22 May 2023||₹400||–||–|
|21 May 2023||₹350||–||–|
|20 May 2023||₹330||–||–|
|19 May 2023||₹300||–||–|
|18 May 2023||₹110||–||–|
|17 May 2023||₹110||–||–|
|16 May 2023||₹110||–||–|
|15 May 2023||₹110||–||–|
|14 May 2023||₹163||–||–|
|13 May 2023||₹163||–||–|
|12 May 2023||₹140||–||–|
|11 May 2023||₹00||–||–|
Remus Pharmaceuticals IPO Detail Video:
Remus Pharmaceuticals IPO Subscription Status (Bidding Detail)
The Remus Pharmaceuticals IPO on May 19, 2023 at 6:57:00 PM was subscribed 57.21 times, with the retail category being subscribed 49.81 times, the NII (Non-Institutional Investor) category being subscribed 229.31 times and the QIB (Qualified-Institutional Buyers) category being subscribed 10.75 times.
Remus Pharmaceuticals IPO Prospectus
|Remus Pharmaceuticals IPO DRHP||Download|
|Remus Pharmaceuticals IPO RHP||Download|
Remus Pharmaceuticals IPO Rating
Remus Pharmaceuticals Company Contact Information
Remus Pharmaceuticals Limited
Registered Office: 1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli bopal Road, Ahmedabad – 380054, Gujarat, India
Telephone No: +079- 2999 9857
Company Secretary and Compliance Officer: Ms. Deval Bakulkumar Patel
Promoters Of Our Company: Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah And Mrs. Anar Swapnil Shah
Remus Pharmaceuticals IPO Registrar
Link Intime India Private Limited
SEBI Registration Number: INR000004058
Address: C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai,
Maharashtra, India – 400 083.
Tel. Number: +91 810 811 4949 Fax- +91 22 4918 6195
Email Id: firstname.lastname@example.org
Investors Grievance Id: email@example.com
Contact Person: Shanti Goapalkrishnan
Remus Pharmaceuticals IPO Lead Manager
Beeline Capital Advisors Private Limited
SEBI Registration Number: INM000012917
Address: 807, Phoenix, Opp. Girish Cold Drinks, Near Vijay Cross Roads, Navrangpura,
Ahmedabad -380009, Gujarat.
Telephone Number: 079 4840 5357
Email Id: firstname.lastname@example.org
Investors Grievance Id: email@example.com
Contact Person: Mr. Nikhil Shah
Remus Pharmaceuticals IPO FAQs
What is the lot size of Remus Pharmaceuticals IPO?
The total size of Remus Pharmaceuticals IPO is ₹47.69 crores and this is a complete fresh Issue.
When will Remus Pharmaceuticals IPO start?
Remus Pharmaceuticals IPO will Open from 17 May 2023 and IPO will Close on 19 May 2023.
What is the open date of Remus Pharmaceuticals IPO?
Remus Pharmaceuticals IPO will open date from 17 May 2023.
What is the last date ( close date ) of Remus Pharmaceuticals IPO?
Remus Pharmaceuticals IPO will close from 19 May 2023.
What is the price band of Remus Pharmaceuticals IPO?
Remus Pharmaceuticals IPO price band is ₹1150 to ₹1229. ( Upper Price Band: ₹1229, Lower Price Band: ₹1150 )
What is the minimum amount required to apply for Remus Pharmaceuticals IPO?
The minimum investment for retailers to apply for Remus Pharmaceuticals IPO is ₹122,900 and the maximum investment is ₹122,900.
What is going on gray market premium of Remus Pharmaceuticals IPO?
View gray market premium of Remus Pharmaceuticals IPO by Clicking Here
How much is the GMP of Remus Pharmaceuticals IPO?
Watch Remus Pharmaceuticals IPO GMP Today: Click Here
What is the allotment date of Remus Pharmaceuticals IPO?
The Allotment Date of Remus Pharmaceuticals IPO is 24 May 2023.
How to check allotment status in Remus Pharmaceuticals IPO?
To check the allotment status of Remus Pharmaceuticals IPO, first of all go to the registrar website by clicking here, select your bad Remus Pharmaceuticals IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Remus Pharmaceuticals IPO?
The Listing Date of Remus Pharmaceuticals IPO is 29 May 2023.
How much will be the listing gain in Remus Pharmaceuticals IPO?
View listing gain of Remus Pharmaceuticals IPO by Clicking Here
How much time Remus Pharmaceuticals IPO is subscribed?
Total 57.21 times subscribed in Remus Pharmaceuticals IPO out of which 49.81 times subscription was done in retail quota, 229.31 times subscription in NII quota and 10.75 times subscription in QIB quota.
How to apply for Remus Pharmaceuticals IPO from Upstox?
Click Here to see how to apply for Remus Pharmaceuticals IPO from Upstox. (step by step)
How to apply for Remus Pharmaceuticals IPO from Zerodha?
Click Here to see how to apply for Remus Pharmaceuticals IPO from Zerodha. (step by step)
How to apply for Remus Pharmaceuticals IPO from Angle One?
Click Here to see how to apply for Remus Pharmaceuticals IPO from Angle One. (step by step)